Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

The New England Journal of Medicine
Tarek A YousryDavid B Clifford

Abstract

Progressive multifocal leukoencephalopathy (PML) was reported to have developed in three patients treated with natalizumab. We conducted an evaluation to determine whether PML had developed in any other treated patients. We invited patients who had participated in clinical trials in which they received recent or long-term treatment with natalizumab for multiple sclerosis, Crohn's disease, or rheumatoid arthritis to participate. The clinical history, physical examination, brain magnetic resonance imaging (MRI), and testing of cerebrospinal fluid for JC virus DNA were used by an expert panel to evaluate patients for PML. We estimated the risk of PML in patients who completed at least a clinical examination for PML or had an MRI. Of 3417 patients who had recently received natalizumab while participating in clinical trials, 3116 (91 percent) who were exposed to a mean of 17.9 monthly doses underwent evaluation for PML. Of these, 44 patients were referred to the expert panel because of clinical findings of possible PML, abnormalities on MRI, or a high plasma viral load of JC virus. No patient had detectable JC virus DNA in the cerebrospinal fluid. PML was ruled out in 43 of the 44 patients, but it could not be ruled out in one patie...Continue Reading

References

May 29, 2004·Current Opinion in Neurology·Igor J Koralnik
Apr 27, 2005·Neurology·George P A RicePeter A Calabresi
Jun 11, 2005·The New England Journal of Medicine·Annette Langer-GouldDaniel Pelletier
Jun 11, 2005·The New England Journal of Medicine·B K Kleinschmidt-DeMasters, Kenneth L Tyler
Jun 11, 2005·The New England Journal of Medicine·Gert Van AsschePaul Rutgeerts
Jun 11, 2005·The New England Journal of Medicine·Burt AdelmanMichael A Panzara
Nov 4, 2005·The New England Journal of Medicine·William J SandbornUNKNOWN Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators

❮ Previous
Next ❯

Citations

Sep 16, 2009·Archives of Neurology·Kenneth L Tyler
May 11, 2011·Archives of Neurology·David B CliffordKenneth L Tyler
Mar 9, 2007·Inflammatory Bowel Diseases·Alessandro LavagnaAngelo Pera
Jun 1, 2007·Inflammatory Bowel Diseases·M Stephen Murphy
Aug 18, 2009·Inflammatory Bowel Diseases·Daniel C Baumgart
Sep 18, 2010·Inflammatory Bowel Diseases·Caihong WangRodney D Newberry
Dec 1, 2006·Der Nervenarzt·Peter Rieckmann, Peter Rieckmann
Sep 23, 2008·Der Nervenarzt·R A Linker, B C Kieseier
Mar 30, 2010·Der Nervenarzt·T Weber, W Köhler
Oct 20, 2009·European Journal of Clinical Pharmacology·Carlo PiccinniNicola Montanaro
May 17, 2008·Zeitschrift für Rheumatologie·C Kneitz, H Wiendl
Apr 25, 2012·Zeitschrift für Rheumatologie·D Meyer-OlsonM Stoll
Nov 16, 2007·Journal of Neurology·Christoph KleinschnitzHeinz Wiendl
Nov 14, 2008·Journal of Neurology·UNKNOWN Multiple Sclerosis Therapy Consensus Group (MSTCG)R Hohlfeld
Mar 28, 2009·Journal of Neurology·P S RommerU K Zettl
Mar 28, 2009·Journal of Neurology·Olaf StüveBernd C Kieseier
Jan 7, 2010·Journal of Neurology·Saud A SadiqEdward W A Brydon
Jun 8, 2011·Journal of Neurology·Kerstin Hellwig, Ralf Gold
Dec 25, 2012·Journal of Neurology·Maria A RoccaMassimo Filippi
Jun 25, 2013·Journal of Neural Transmission·Clemens WarnkeHans-Peter Hartung
Nov 13, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·P IaffaldanoMaria Trojano
Jan 15, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·A GhezziUNKNOWN MS-SIN Study Group
Apr 25, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·R LanzilloV Brescia Morra
Feb 6, 2007·Modern Rheumatology·Motohisa YamamotoKohzoh Imai
Dec 30, 2011·Inflammopharmacology·Saskia Thomas, Daniel C Baumgart
Feb 5, 2011·Irish Journal of Medical Science·B Bailey
Nov 16, 2006·Current Gastroenterology Reports·Geert D'Haens, Marco Daperno
Apr 2, 2008·Current Gastroenterology Reports·Fernando S Velayos, William J Sandborn
Jul 17, 2008·Current HIV/AIDS Reports·Elizabeth A Hartman, DeRen Huang
May 10, 2007·Current Neurology and Neuroscience Reports·Eric C Klawiter, Anne H Cross
Aug 21, 2008·Current Neurology and Neuroscience Reports·John W RoseNoel Carlson
Aug 12, 2006·Current Treatment Options in Gastroenterology·Pieter C F Stokkers, Daniel W Hommes
Apr 15, 2009·Current Treatment Options in Neurology·John W RoseNoel G Carlson
Aug 13, 2011·Current Treatment Options in Neurology·E Ann Yeh
Feb 3, 2009·Immunologic Research·Young-Min HyunMinsoo Kim
Jan 12, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jeremy Chataway, David H Miller
Apr 6, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Thomas WilliamsLaura Azzopardi
Apr 24, 2013·Drugs·Rehiana AliPaolo Antonio Muraro
Oct 9, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Paolo A Muraro, Bibiana Bielekova

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

© 2021 Meta ULC. All rights reserved